{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:45:49Z","timestamp":1788201949536,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81701552"],"award-info":[{"award-number":["No. 81701552"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81873882"],"award-info":[{"award-number":["No. 81873882"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81701552"],"award-info":[{"award-number":["No. 81701552"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["No. 2021JJ40922"],"award-info":[{"award-number":["No. 2021JJ40922"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["No.2022JJ30857"],"award-info":[{"award-number":["No.2022JJ30857"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["No. 2021JJ40922"],"award-info":[{"award-number":["No. 2021JJ40922"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hunan Province Innovation Platform and Talent Plan\uff0cClinical Medical Research Center Project","award":["2023SK4015"],"award-info":[{"award-number":["2023SK4015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-74940-1","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:02:54Z","timestamp":1730106174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical characteristics of idiopathic inflammatory myopathies related to anti-SRP: a single center experience"],"prefix":"10.1038","volume":"14","author":[{"given":"Qi","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinshen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"74940_CR1","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/jamaneurol.2015.1207","volume":"72","author":"CD Kassardjian","year":"2015","unstructured":"Kassardjian, C. D. et al. Clinical features and treatment prognosis of necrotizing autoimmune myopathy. JAMA Neurol.72, 996\u20131003 (2015).","journal-title":"JAMA Neurol."},{"key":"74940_CR2","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1136\/annrheumdis-2013-205127","volume":"74","author":"C Dobloug","year":"2015","unstructured":"Dobloug, C. et al. Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort. Ann. Rheum. Dis.74, 1551\u20131556 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"74940_CR3","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","volume":"75","author":"K Mariampillai","year":"2018","unstructured":"Mariampillai, K. et al. Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies. JAMA Neurol.75, 1528\u20131537 (2018).","journal-title":"JAMA Neurol."},{"key":"74940_CR4","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/brain\/aww054","volume":"139","author":"Y Allenbach","year":"2016","unstructured":"Allenbach, Y. et al. High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody. Brain. 139, 2131\u20132135 (2016).","journal-title":"Brain"},{"key":"74940_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrrheum.2018.41","volume":"14","author":"IE Lundberg","year":"2018","unstructured":"Lundberg, I. E., De Visser, M. & Werth, V. P. Classification of myositis. Nat. Rev. Rheumatol.14, 269\u2013278 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"74940_CR6","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMra1402225","volume":"372","author":"MC Dalakas","year":"2015","unstructured":"Dalakas, M. C. Inflammatory muscle diseases. N Engl. J. Med.372, 1734\u20131747 (2015).","journal-title":"N Engl. J. Med."},{"key":"74940_CR7","doi-asserted-by":"publisher","first-page":"9507","DOI":"10.1073\/pnas.83.24.9507","volume":"83","author":"W Reeves","year":"1986","unstructured":"Reeves, W., Nigam, S. & Blobel, G. Human autoantibodies reactive with the signal-recognition particle. PNAS. 83, 9507\u20139511 (1986).","journal-title":"PNAS"},{"key":"74940_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3109\/03009742.2015.1054876","volume":"45","author":"H Hanaoka","year":"2016","unstructured":"Hanaoka, H. et al. Anti-signal recognition particle antibody in patients without inflammatory myopathy: A survey of 6180 patients with connective tissue diseases. Scand. J. Rheumatol.45, 36\u201340 (2016).","journal-title":"Scand. J. Rheumatol."},{"key":"74940_CR9","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/acr.20219","volume":"62","author":"R Valiyil","year":"2010","unstructured":"Valiyil, R. et al. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: A case series. Arthritis Care Res.62, 1328\u20131334 (2010).","journal-title":"Arthritis Care Res."},{"key":"74940_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-015-0277-y","volume":"10","author":"S Suzuki","year":"2015","unstructured":"Suzuki, S. et al. Inflammatory myopathy with anti-signal recognition particle antibodies: Case series of 100 patients. Orphanet. J. Rare Dis.10, 1\u20139 (2015).","journal-title":"Orphanet. J. Rare Dis."},{"key":"74940_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/acr.22920","volume":"69","author":"I Pinal-fernandez","year":"2017","unstructured":"Pinal-fernandez, I. et al. Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle. Arthritis Care Res.69, 263\u2013270 (2017).","journal-title":"Arthritis Care Res."},{"key":"74940_CR12","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.2169\/internalmedicine.0303-17","volume":"57","author":"T Kusumoto","year":"2018","unstructured":"Kusumoto, T. et al. Development of necrotizing myopathy following interstitial lung disease with anti-signal recognition particle antibody. Intern. Med.57, 2045\u20132049 (2018).","journal-title":"Intern. Med."},{"key":"74940_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10067-014-2512-7","volume":"34","author":"SK Basnayake","year":"2015","unstructured":"Basnayake, S. K. et al. Inflammatory myopathy with anti-SRP antibodies: Case series of a south Australian cohort. Clin. Rheumatol.34, 603\u2013608 (2015).","journal-title":"Clin. Rheumatol."},{"key":"74940_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","volume":"28","author":"Y Allenbach","year":"2018","unstructured":"Allenbach, Y. et al. 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, the Netherlands, 14\u201316 October 2016. Neuromuscul. Disord28, 87\u201399 (2018).","journal-title":"Neuromuscul. Disord"},{"key":"74940_CR15","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/mus.25575","volume":"56","author":"Y Zhao","year":"2017","unstructured":"Zhao, Y. et al. Childhood autoimmune necrotizing myopathy with anti-signal recognition particle antibodies. Muscle Nerve. 56, 1181\u20131187 (2017).","journal-title":"Muscle Nerve"},{"key":"74940_CR16","doi-asserted-by":"crossref","unstructured":"Hochberg MC. Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum.\u00a040, 1997 (1997).","DOI":"10.1002\/art.1780400928"},{"key":"74940_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"F Arnett","year":"1988","unstructured":"Arnett, F. et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum.31, 315\u2013324 (1988).","journal-title":"Arthritis Rheum."},{"key":"74940_CR18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali, C. et al. Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis.61, 554\u2013558 (2002).","journal-title":"Ann. Rheum. Dis."},{"key":"74940_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan, A. & Peter, J. Polymyositis and dermatomyositis. N Engl. J. Med.292, 344\u2013347 (1975).","journal-title":"N Engl. J. Med."},{"key":"74940_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","volume":"84","author":"Y Troyanov","year":"2005","unstructured":"Troyanov, Y. et al. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Med. (Baltim).84, 231\u2013249 (2005).","journal-title":"Med. (Baltim)."},{"key":"74940_CR21","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ana.410380504","volume":"38","author":"RC Griggs","year":"1995","unstructured":"Griggs, R. C. et al. Inclusion body myositis and myopathies. Ann. Neurol.38, 705\u2013713 (1995).","journal-title":"Ann. Neurol."},{"key":"74940_CR22","doi-asserted-by":"crossref","unstructured":"Jennette JC et al. 2012 revised international chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum.\u00a065, 1\u201311 (2013).","DOI":"10.1007\/s10157-013-0869-6"},{"key":"74940_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1148\/radiol.2361031674","volume":"236","author":"DA Lynch","year":"2005","unstructured":"Lynch, D. A. et al. Idiopathic interstitial pneumonias: CT features. Radiology. 236, 10\u201321 (2005).","journal-title":"Radiology"},{"key":"74940_CR24","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E von Elm","year":"2007","unstructured":"von Elm, E. et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. PLoS Med.4, e296 (2007).","journal-title":"PLoS Med."},{"key":"74940_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/art.11484","volume":"50","author":"AH Kao","year":"2004","unstructured":"Kao, A. H. et al. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum.50, 209\u2013215 (2004).","journal-title":"Arthritis Rheum."},{"key":"74940_CR26","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/art.1780330908","volume":"33","author":"IN Targoff","year":"1990","unstructured":"Targoff, I. N., Johnson, A. E. & Miller, F. W. Antibody to signal recognition particle in polymyositis. Arthritis Rheum.33, 1361\u20131370 (1990).","journal-title":"Arthritis Rheum."},{"key":"74940_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/ard.60.2.116","volume":"60","author":"R Brouwer","year":"2001","unstructured":"Brouwer, R. et al. Autoantibody profiles in the sera of European patients with myositis. Ann. Rheum. Dis.60, 116\u2013123 (2001).","journal-title":"Ann. Rheum. Dis."},{"key":"74940_CR28","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/mus.24970","volume":"53","author":"M Apiwattanakul","year":"2016","unstructured":"Apiwattanakul, M. et al. Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy. Muscle Nerve. 53, 925\u2013932 (2016).","journal-title":"Muscle Nerve"},{"key":"74940_CR29","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","volume":"73","author":"T Miller","year":"2002","unstructured":"Miller, T. et al. Myopathy with antibodies to the signal recognition particle: Clinical and pathological features. J. Neurol. Neurosurg. Psychiatry73, 420\u2013428 (2002).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"74940_CR30","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/art.30344","volume":"63","author":"O Benveniste","year":"2011","unstructured":"Benveniste, O. et al. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Arthritis Rheum.63, 1961\u20131971 (2011).","journal-title":"Arthritis Rheum."},{"key":"74940_CR31","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s12026-015-8774-6","volume":"64","author":"C Picard","year":"2016","unstructured":"Picard, C. et al. Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: A multicentric study. Immunol. Res.64, 677\u2013686 (2016).","journal-title":"Immunol. Res."},{"key":"74940_CR32","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","volume":"87","author":"Y Watanabe","year":"2016","unstructured":"Watanabe, Y. et al. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. J. Neurol. Neurosurg. Psychiatry. 87, 1038\u20131044 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"74940_CR33","doi-asserted-by":"publisher","unstructured":"Qureshi, A., Brown, D. & Brent, L. Anti-signal recognition particle antibody-associated severe interstitial lung disease requiring lung transplantation. Cureus12, https:\/\/doi.org\/10.7759\/cureus.7962 (2020) (Epub ahead of print).","DOI":"10.7759\/cureus.7962"},{"key":"74940_CR34","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1001\/archneurol.2011.1728","volume":"69","author":"S Suzuki","year":"2012","unstructured":"Suzuki, S. et al. Myopathy associated with antibodies to signal recognition particle: Disease progression and neurological outcome. Arch. Neurol.69, 728\u2013732 (2012).","journal-title":"Arch. Neurol."},{"key":"74940_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-020-1599-5","volume":"20","author":"A Hara","year":"2020","unstructured":"Hara, A. et al. Secondary cardiac involvement in anti-SRP-antibody-positive myopathy: An 87-year-old woman with heart failure symptoms as the first clinical presentation. BMC Neurol.20, 1\u20135 (2020).","journal-title":"BMC Neurol."},{"key":"74940_CR36","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3109\/s10165-008-0139-8","volume":"19","author":"T Takada","year":"2009","unstructured":"Takada, T. et al. Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies. Mod. Rheumatol.19, 156\u2013164 (2009).","journal-title":"Mod. Rheumatol."},{"key":"74940_CR37","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.alit.2016.10.009","volume":"66","author":"R Togawa","year":"2017","unstructured":"Togawa, R. et al. Three cases of interstitial pneumonia with anti-signal recognition particle antibody. Allergol. Int.66, 485\u2013487 (2017).","journal-title":"Allergol. Int."},{"key":"74940_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1056\/NEJMc1900045","volume":"381","author":"Z Chen","year":"2019","unstructured":"Chen, Z., Wang, X. & Ye, S. Tofacitinib in amyopathic dermatomyositis\u2013associated interstitial lung disease. N Engl. J. Med.381, 291\u2013293 (2019).","journal-title":"N Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74940-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74940-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74940-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:05:46Z","timestamp":1730106346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74940-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["74940"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-74940-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The ethical board of the second Xiangya Hospital approved the study (ID: 2020-K011). All patients gave written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"The manuscript without peer review process was online with pre-print (DOI:\n                      \n                      ).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Preprint statement"}}],"article-number":"25788"}}